ASX lithium names slide on spodumene hit, UBS says stocks look cheap
July 17, 2026, 4:51 AM EDT. ASX-listed lithium stocks are down 20% to more than 40% after spodumene prices slipped, hit by CATL’s Jianxiawo mine coming back online and more supply from Australia. Spodumene fell from US$2,280 to US$2,180 a tonne. But with production still below US$1,000/t, UBS says that drop opens up value for buyers. The bank set price targets for PLS Group at $5.60 versus $4.37 now, IGO at $9.65 vs $6.75, Liontown at $2.50 vs $1.35, and PMET Resources at 90c vs 44c. UBS noted capital demands stay high for sector growth, though it expects the June quarter to show better free cash flow and margins off the rebound in lithium prices since mid-2023, with value creeping back in.
Barry FitzGerald: Lithium dip is all right…
Prime Value's Tortoise Game in Small Caps: Steady Picks Over Flashy Returns
July 17, 2026, 4:50 AM EDT. Prime Value Asset Management sticks to a tortoise-over-the-hare style in small-cap stock picking, putting certainty ahead of chasing bigger returns. Portfolio manager Mike Younger looks for small industrials with solid market positions and less volatility, aiming for stocks that hold up better in tough markets. Small-cap industrials have lagged big caps and small resources since 2020, but Younger sees a gap in valuations and is finding value there. The fund invests outside the top 100 companies by market cap, with portfolio holdings around $1.7 billion on average. Higher rates have made things tougher for small caps, but the Reserve Bank of Australia’s recent pause could relieve some of that pressure. Prime Value’s favorites now include Cuscal, Dalrymple Bay Infrastructure, Pinnacle Investment, Regis Healthcare, and Auckland International Airport.
Criterion: The fund with the tortoise-over…
ASX 200 Dips as Miners Weigh; Burberry Flags Caution on Guidance
July 17, 2026, 4:36 AM EDT. The ASX 200 was lower with sharp declines in copper, lithium, and uranium miners after weaker commodity prices and demand worries hit the sector. Volatile energy transition minerals also saw heavier selling. Healthcare nudged up 0.05%, helped by talk of potential U.S. FDA rule changes on peptides. Microba Life Sciences posted a 45% revenue lift for Q4 FY26. Burberry dropped even after posting 5% growth in Q1 comparable retail sales, keeping a cautious tone for the year on the back of geopolitical risks and softer tourism in EMEIA. Wise Group PLC saw more Q1 customers for its fintech cross-border services, which showed some staying power even as competition heats up.
Stock Market Today: Live Updates 17.07.202…
Sangiovese: Versatile Red Gets Winter Push, Market Looks Up
July 17, 2026, 4:35 AM EDT.Sangiovese continues to win over drinkers for its flexibility and food pairing chops. The grape brings a mix of body, tannins and acidity that works well with tomato sauces, lamb, roast veg and hard cheese. Taltarni’s 2023 Victorian Sangiovese comes structured, drawing in both cabernet and pinot noir fans. Sangiovese adapts to changing climates and there are more than 100 registered clones, which could help push it further on the world stage. This week’s deal includes sangiovese plus other reds-Pinot Meunier and Grenache Carignan-nearly half off at $16.99 a bottle, as buyers pick up on lesser-known, food-friendly wines.
From Italy With Love: Sangiovese ultimate …
ASX 200 drops as miners slide, copper, lithium and uranium stocks fall
July 17, 2026, 4:07 AM EDT. The ASX 200 slipped on heavy selling in the mining sector, with copper, lithium, and uranium shares dragging the market lower. Investors sold off resource names as weaker commodity prices and demand worries hit. The slump weighed on the mining-focused index as volatility picked up in critical minerals tied to energy transition themes.
Evening Wrap: ASX 200 slides as mining blo…
ASX Health Care Inches Up; FDA Set to Loosen Grip on Peptides
July 17, 2026, 4:06 AM EDT. The S&P/ASX 200 Health Care Index ticked up 0.05% this week, slightly ahead of the flat S&P/ASX 200. Ongoing Middle East risks and concern over US-China election meddling weighed on mood. The US FDA is moving to relax rules on some peptides, giving licensed compounding pharmacies the ability to make drugs that sit in a legal grey area. Peptides are short chains of proteins used in medicine-GLP-1s for diabetes are established, but others like BPC-157 face scrutiny and a black market. An FDA panel votes on these changes late July. Tetratherix could benefit if the rules expand its precision medicine work. Microba Life Sciences posted a 45% jump in core testing revenue to $2.53 million for Q4 FY26, signaling sector growth.
Iain Wilkie, for Scott Power: Healthcare l…
Burberry (BRBY) Slides After Q1 Sales Gain, Outlook Stays Cautious
July 17, 2026, 4:05 AM EDT. Burberry shares slipped after its Q1 update. Comparable retail sales rose 5%, lifted by Womenswear, Menswear, Accessories, and Childrenswear. The Americas booked 12% growth, Greater China was up 9% with Gen Z support, and Asia Pacific added 3%. EMEIA fell 3%, with geopolitics and fewer tourists taking a toll. Retail revenue came in at £455 million, up 5%, helped by new polo galleries and scarf bars in stores. Burberry raised its wholesale guidance but stuck with a cautious view on full-year revenue and margin as the outlook remains shaky. Some analysts called the numbers steady but still short on what it would take to turn sentiment in luxury stocks.
Burberry shares dip despite steady growth …
Wise Group PLC sees Q1 jump as customer use climbs
July 17, 2026, 4:04 AM EDT.Wise Group PLC (LSE:WISE, NASDAQ:WSE) posted solid first-quarter growth, with more customers using its fintech platform. The company said demand stayed strong for its cross-border transfer services. Wise kept up a push on low-cost international payments, helping it bring in more users. Management said the growth backs confidence in the platform as fintech competition stays tough. Some in the market say Wise’s numbers show resilience across the sector as customer needs shift.
